Funding for this research was provided by:
Text and Data Mining valid from 2018-06-30
Received: 14 March 2018
Accepted: 30 May 2018
First Online: 30 June 2018
Ethics approval and consent to participate
: The Rotterdam Study was approved by the medical ethics committee according to the Population Study Act Rotterdam Study, as well as by the Ministry of Health, Welfare and Sports of the Netherlands (PG/OGZ 3098756). Written informed consent was obtained from all participants prior to study recruitment.
: Not applicable
: SH, FJW, MMV, HV, MKI, MAI and MWV report no competing interests. ES is a shareholder of ADx NeuroSciences NV, Gent, Belgium, which provided the kits for plasma assessment of amyloid-β levels.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.